Study on Doses of Inhaled ALX1 in Adults With Bronchiectasis

NCT07731919 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchiectasis Adult

Interventions

DRUG: ALX1
DRUG: Placebo

Sponsor

Vast Therapeutics